The EU has committed $32m of funding to a research consortium that aims to commercialise stem cell tissue engineering technologies over the next four years, according to reports.

The project, named Systems Approach to Tissue Engineering Products and Processes (Steps), will build on a solid foundation of research to learn how to build specific tissues - such as skin, bone or cartilage - in quantities that would make them useful to patients.

Dr. David Williams, project leader and director of the UK Centre for Tissue Engineering, told Wired.com: "Despite plenty of progress, tissue engineering has not achieved tremendous clinical success or commercial success."

He explained that although small samples of various tissues can be grown in the lab, the process needs to be scaled up, and sped up, if it is to be good enough for skin grafts, for example, in the real world.

Making the leap from the lab to the surgery will not be a simple task, but Williams is confident that the team will be testing clinical treatments within four years.

The team will also be investigating exactly how it is that stem cells can turn into other cells. Williams says that although in many cases scientists have worked out how it happens, he wants to build a working model of the process. ®

Related stories

• UK gets £100m stem cell boost (2 December 2005)
• Stem cell pioneer steps down over egg ethics (24 November 2005)
• Stem cell researchers want watchdogs for human tests (16 November 2005)
• Stem cell hopefuls swamp Korean research website (1 November 2005)
• Researchers name gene suspected in Tourette's syndrome (14 October 2005)
• Stem cell hype could trigger backlash (5 September 2005)
• Scientists brew up pure nerve stem cells (16 August 2005)
• South Koreans clone dog (4 August 2005)
• From stem cell to brain cell in a petri dish (14 June 2005)
• Bush pledges to veto stem cell bill (23 May 2005)
• Scientists hail stem cell breakthrough (20 May 2005)